NCT06421870View on ClinicalTrials.gov

Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Dapagliflozin 10mg Tab

Patients will be given dapagliflozin 10 mg once daily

DRUG

Pentoxifylline 400 MG

Patients will be given pentoxyifylline 400 mg twice daily

Trial Locations (1)

1181

RECRUITING

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER